Cas No.: | |
Chemical Name: | (E)-2-((2-(5,6-dimethoxybenzo[d]thiazol-2-yl)hydrazono)methyl)benzo[b]thiophen-3-ol |
Synonyms: | cIAP1 E3 ligase inhibitor D19-14|cIAP1 inhibitor D19-14 |
Formula: | C18H15N3O3S2 |
M.Wt: | 385.456 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | cIAP1 E3 ligase inhibitor D19-14 (cIAP1 inhibitor D19-14) is an improved analog of D19, demonstrates significantly increased ability to inhibit cIAP1 autoubiquitination and reduce protein levels of c-MYC in vitro; D19-14 is more potent in inhibiting the proliferation of cancer cells than D19, D19-14 exhibits acceptable pharmacokinetics properties in vivo, effectively decreases the levels of c-MYC protein in tumors in cancer xenograft model. |